KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

ACRX Predictions History

4 years ago
joe1234 predicted that ACRX for 2019-06-18 is going $2.48 (5.98%)

4 years ago
joe1234 predicted that ACRX for 2019-06-14 is going $2.48 (5.08%)

4 years ago
joe1234 predicted that ACRX for 2019-06-12 is going $2.48 (5.08%)

4 years ago
joe1234 predicted that ACRX for 2019-06-03 is going $2.74 (5.79%)

4 years ago
joe1234 predicted that ACRX for 2019-05-22 is going $3.04 (4.83%)

4 years ago
joe1234 predicted that ACRX for 2019-05-20 is going $3.10 (6.90%)

4 years ago
GoldenNugget predicted that ACRX for 2019-05-07 is going $3.65 (0.92%)

4 years ago
NameNotImportant predicted that ACRX for 2019-05-06 is going $3.86 (5.46%)

4 years ago
GoldenNugget predicted that ACRX for 2019-05-06 is going $3.57 (-2.55%)

4 years ago
joe1234 predicted that ACRX for 2019-05-03 is going $3.43 (-6.28%)

Click to get the best stock tips daily for free!

About AcelRx Pharmaceuticals

AcelRx Pharmaceuticals AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai... ACRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT